Testing effectiveness (Phase 2)Looking for participantsNCT05668884
What this trial is testing
GEMOX Combined With Donafenib and Tislelizumab in Advanced Biliary Tract Carcinoma
Who this might be right for
Biliary Tract Carcinoma
Fudan University 93
Showing 20 of 0 results